To evaluate the potential molecular mechanism of KRS to improve T2DM, key genes of the insulin signaling pathway including IRS-1, PI3K, p-PI3K, Akt, p-Akt, and Glut4 were investigated using western blotting. This evidence concerns the gene INS and type 2 diabetes mellitus.